Publikationen, an denen er mitarbeitet Carmen De Mendoza Fernandez (98)

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Genetic signature detected in T cell receptors from patients with severe COVID-19

    iScience, Vol. 26, Núm. 10

  3. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

    Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548

  4. Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain

    Journal of Clinical Virology, Vol. 167

  5. Rebound in sexually transmitted infections after the COVID-19 pandemic

    AIDS reviews, Vol. 26, Núm. 3, pp. 127-135

  6. Safety considerations in the management of hepatitis C and HIV co-infection

    Expert Opinion on Drug Safety, Vol. 22, Núm. 5, pp. 363-372

  7. Treatment of hepatitis delta and HIV infection

    Liver International, Vol. 43, Núm. S1, pp. 108-115

  8. Viral hepatitis in persons living with HIV in the post-COVID era

    AIDS reviews, Vol. 25, Núm. 1, pp. 1-13

2022

  1. Envisioning hepatitis delta cure without functional hepatitis B cure

    AIDS reviews, Vol. 24, Núm. 4, pp. 200

  2. Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies

    Journal of Viral Hepatitis, Vol. 29, Núm. 9, pp. 777-784

  3. Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain

    Hepatology International, Vol. 16, Núm. 5, pp. 1161-1169

  4. Oral antivirals for the prevention and treatment of SARS-CoV-2 infection

    AIDS Reviews, Vol. 24, Núm. 1

  5. Pre-Exposure Prophylaxis for viral infections other than HIV

    Infezioni in Medicina, Vol. 30, Núm. 3, pp. 362-371

  6. Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases

    Future Microbiology, Vol. 17, Núm. 11, pp. 887-897

2021

  1. Envisioning a hepatitis delta cure with new antivirals

    Future Microbiology, Vol. 16, Núm. 13, pp. 927-930

  2. Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain

    International Journal of Infectious Diseases, Vol. 112, pp. 81-88

  3. Main differences between the first and second waves of COVID-19 in Madrid, Spain

    International Journal of Infectious Diseases, Vol. 105, pp. 374-376

  4. Third wave of COVID-19 in Madrid, Spain

    International Journal of Infectious Diseases, Vol. 107, pp. 212-214

2020

  1. Advances in hepatitis B therapeutics

    Therapeutic Advances in Infectious Disease, Vol. 7

  2. COVID-19 comes 40 years after aids – Any lesson?

    AIDS Reviews, Vol. 22, Núm. 1, pp. 1-15